← Back to signals
CVS
AVOIDCVS Health Corporation
Health Care
1.56
PEGY ratio
Rank #312
Why This Matters
This stock appears overvalued relative to its growth and dividend yield. Strong projected growth of 267.7% annually over 5 years. Pays a 2.6% dividend yield.
CVS trades at 43.1x earnings against 25.0% capped growth (actual 267.7%) + 2.6% yield (PEGY 1.56). The valuation appears stretched relative to the available growth and income.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
- • Growth rate capped at 25% for PEGY calculation (actual: 267.7%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.
Scan date: 2026-06-19
Valuation
43.1x
P/E Ratio
Growth
267.7%
5yr EPS
Income
2.6%
Div Yield
PEGY Components
PEGY Score1.56
Denominator27.6%
EPS (TTM)$2.28
Market Data
Price$98.32
ExchangeNYSE
S&P 500
What Changed
PEGY Score
1.62→1.56(-0.06)
Rank
#312→#312(0 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only